Thema
Review
Antibodies, Monoclonal, Humanized
9.836
Journal Article
9.708
Antibodies, Monoclonal
5.585
Antineoplastic Agents
2.187
Research Support, Non-U.S. Gov't
1.794
EC 2.7.10.1
1.569
Bevacizumab
1.371
2S9ZZM9Q9V
1.368
Trastuzumab
1.127
P188ANX8CK
1.126
Angiogenesis Inhibitors
1.029
Receptor, ErbB-2
720
Vascular Endothelial Growth Factor A
715
Tumor Necrosis Factor-alpha
712
Adalimumab
699
FYS6T7F842
697
Cetuximab
691
PQX0D8J21J
689
Immunosuppressive Agents
673
Infliximab
633
B72HH48FLU
626
ErbB Receptors
599
Case Reports
596
tocilizumab
581
I031V2H011
575
Immunoglobulin G
561
Systematic Review
544
Antirheumatic Agents
534
pembrolizumab
525
Rituximab
520
DPT0O3T46P
517
4F4X42SYQ6
512
Quinazolines
443
Etanercept
439
OP401G7OJC
438
Meta-Analysis
424
Receptors, Tumor Necrosis Factor
392
Immunologic Factors
387
3A189DH42V
382
Alemtuzumab
382
English Abstract
375
Omalizumab
373
2P471X1Z11
368
Protein Kinase Inhibitors
367
Antibodies, Monoclonal, Murine-Derived
359
4EQZ6YO2HI
349
Denosumab
349
Research Support, N.I.H., Extramural
341
Anti-Inflammatory Agents
327
mehr ...